Thorsten Braun

Learn More
We describe the characteristics and outcome of inflamma-tory arthritis in patients with myelodysplastic syndrome (MDS) in a French multicenter retrospective study. Twenty-two patients with MDS (median age, 77.5 yr Einterquartile range, 69Y81^; 10 women) were included. Inflammatory arthritis presented as polyarthritis in 17 cases (77%) and with symmetric(More)
The cytidine analogues azacytidine and 5-aza-2'-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents results from a cytotoxic or an epigenetic effect. In this study, we address this question in chronic(More)
In Denmark as in Germany the health care sector is coming increasingly under pressure: the ageing of the society will in the near future result in a drastic increase in the number people in need of care, while at the same time there is already a shortage of health professionals in some regions. Therefore the qualifications of health workers, as well as the(More)
During the preparation of Fig. 3A for the final version of this manuscript, the authors have assembled immunoblots from different cell lines without clearly indicating the borders between blots. A corrected version of Fig. 3A in which borders between blots are clearly indicated, with the loading controls for all the membranes subjected to immunoblot(More)
  • 1